Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Charlotte's Web is a full-spectrum hemp extract containing cannabidiol (CBD) and other cannabinoids with less than 0.3% THC. It was originally developed by the Stanley Brothers in 2012 for Charlotte Figi, a girl with Dravet syndrome, whose seizures were significantly reduced by using this product. The extract is derived from a specific strain of hemp that maintains a high CBD to THC ratio (approximately 30:1). Charlotte's Web products are extracted using either carbon dioxide (CO2) or isopropyl alcohol methods to preserve various beneficial compounds including cannabinoids, terpenes, and flavonoids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on charlotte's web.